Van Plew Daniel P — SEC Form 4 filings
SEC reporting owner CIK 1411984. 6 Form 4 filings on record with FilingPulse; latest filed 2025-12-11.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-02-13 to 2025-12-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 13 legs across 1 filing — 10,434 shares, $9,831,727 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: sale of 4,261 shares @ $940.44 ($4,007,215) in REGENERON PHARMACEUTICALS, INC., filed 2024-02-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. (REGN) | EVP & General Mgr, Industrial | 6 | — | 13 legs · 10,434 sh · $9,831,727 | 14 |
Form 4 filings — Van Plew Daniel P
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-12-11 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Tax withholding (F): 2,552 @ $701.51 | EDGAR |
| 2025-12-09 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 3,715 @ $0 · Tax withholding (F): 1,906 @ $712.94 · Grant/award (A): 18,315 (derivative) @ $0 | EDGAR |
| 2024-12-18 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Tax withholding (F): 969 @ $730.81 | EDGAR |
| 2024-12-10 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 3,499 @ $0 · Tax withholding (F): 492 @ $787 · Grant/award (A): 13,472 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 439 @ $937.94 · Sale (S): 226 @ $938.13 · Sale (S): 750 @ $939.60 · Sale (S): 4,261 @ $940.44 · Sale (S): 275 @ $941.41 · Sale (S): 2,691 @ $943.51 · +7 more | EDGAR |
| 2024-02-13 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 12,250 @ $372.46 · Tax withholding (F): 8,600 @ $951.68 · Option exercise (M): 23,125 @ $381.40 · Tax withholding (F): 16,341 @ $951.68 · Option exercise (M): 12,250 (derivative) @ $0 · Option exercise (M): 23,125 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1411984 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →